JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit

Core Points - Rosen Law Firm is reminding purchasers of Jasper Therapeutics, Inc. securities about the lead plaintiff deadline on November 18, 2025 for those who bought shares between November 30, 2023 and July 3, 2025 [1] Group 1 - The Class Period for Jasper Therapeutics securities is defined as between November 30, 2023 and July 3, 2025 [1] - Investors who purchased securities during this period may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]